Format:
12
ISSN:
1557-7422
Content:
Gamma-Norton and colleagues utilize a technology that relies on the use of packaging cell lines with predefined integration sites to evaluate the performance of several retroviral vectors. According to the authors, this approach enables the systematic design and evaluation of the efficiency and safety of retroviral vectors optimized for a given producer cell line.
Note:
Gesehen am 14.11.2023
In:
Human gene therapy, New York, NY : Liebert, 1990, 21(2010), 8 vom: Aug., Seite 979-991, 1557-7422
In:
volume:21
In:
year:2010
In:
number:8
In:
month:08
In:
pages:979-991
In:
extent:12
Language:
English
DOI:
10.1089/hum.2009.089
URL:
Volltext
(lizenzpflichtig)
URL:
Volltext
(lizenzpflichtig)
Bookmarklink